Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-08-28 Proxy Solicitation & In…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于召开2025年第二次临时股东会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice regarding the convening of the 2025 second extraordinary general meeting (临时股东会) of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items, registration procedures, and proxy authorization forms. The content focuses on informing shareholders about the meeting logistics and agenda, including a proposal to apply for and use a credit line from a bank. There are no financial statements, earnings data, or detailed management analysis present. The document is essentially a meeting notice and proxy solicitation material for a shareholder meeting, not a report or announcement of financial results or corporate governance changes. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI). The document length is 3078 characters, which is typical for such notices and not a full report. Hence, the classification is PSI with high confidence.
2025-08-28 Chinese
国泰海通证券股份有限公司关于上海辰光医疗科技股份有限公司控股股东以及实际控制人为公司提供担保暨关联交易的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from a sponsoring institution (国泰海通证券股份有限公司) regarding a related-party transaction where the controlling shareholder and actual controller provides a guarantee for the company. It discusses the background, necessity, pricing, and approval procedures of the guarantee and related-party transaction. There are no financial statements or detailed financial data presented. The document is a regulatory compliance and verification report related to a specific transaction and does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a simple announcement of a report publication either. The content aligns best with a Regulatory Filing (RNS) as it is a compliance and verification document related to regulatory requirements and disclosures about related-party transactions and guarantees.
2025-08-28 Chinese
第五届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 20th meeting of the 5th Board of Directors of Shanghai Chunguang Medical Technology Co., Ltd. It includes details about the meeting's convening, attendance, and the approval of the 2025 semi-annual report and a special report on the management and use of raised funds. The document references the actual semi-annual report and related reports being disclosed separately on the official exchange platform, indicating this document itself is not the report but an announcement of board resolutions related to these reports. The content focuses on board meeting decisions rather than the full financial report or detailed financial data. Therefore, this fits best under Board/Management Information (MANG), as it announces board meeting resolutions and approvals.
2025-08-27 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or "Interim Report" for the period January 1, 2025 to June 30, 2025. It contains detailed financial data including revenue, profit, assets, liabilities, and other accounting metrics. It also includes sections on company overview, business operations, risk factors, and management discussion. The length is substantial (15,000 characters) and it contains actual financial statements and substantive financial analysis. The document explicitly states it is a half-year report and is unaudited, which aligns with the definition of an Interim / Quarterly Report (IR). It is not an announcement or a brief summary, nor is it a full annual report (10-K). Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2025
2025-08-27 Chinese
关于开立募集资金现金管理专用结算账户的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Shanghai Chenguang Medical Technology Co., Ltd. regarding the opening of a dedicated settlement account for cash management of raised funds. It details the board meeting approval for using idle raised funds for cash management, the types of financial products to be purchased, and the specifics of the new bank account opened for this purpose. The document is short (1042 characters) and primarily serves as an announcement of a corporate action related to capital management, not a financial report or detailed financial data. It does not contain financial statements or detailed analysis but rather informs about a financing-related operational update. Therefore, it fits best under Capital/Financing Update (CAP).
2025-08-27 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '半年度报告摘要' which translates to 'Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, revenue, and shareholder information for the period ending June 30, 2025. The content includes comprehensive financial figures, business descriptions, and operational details typical of an interim or quarterly report. The document length is 7600 characters, which is sufficient to contain substantive financial data rather than just an announcement or summary. There is no indication that this is a full annual report (10-K) or an earnings release (ER) which are usually shorter and more summary-focused. The presence of detailed financial statements and analysis confirms it is an Interim / Quarterly Report (IR). H1 2025
2025-08-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.